Updated: April 13, 2020

This NABH-Covid-19 Resources page is designed to help NABH members access important and applicable resources as they navigate the Covid-19 pandemic. The first section includes PDF documents from NABH and other organizations, and the second section includes links to federal guidance and other applicable information from federal agencies and non-government organizations.

Thank you for the excellent care you and your teams continue to provide during this difficult time. Please write to us with concerns or questions at nabh@nabh.org.

Latest Documents

Infection Control

  • 4-9-20: CMS Updated Guidance on Infection Control for ICF/IID & PRTF
  • 4-9-20: CMS Updated Guidance on Infection Control for Hospitals
  • CDC Covid-19 and Infection Control Guidance
  • CMS Infection Control Guidance for Outpatient Settings
  • The Joint Commission’s Covid-19 Infection Control Guidance
  • National Institute of Environmental Health Sciences Resources


  • 4-6-20: AHA Urges SBA to Ensure Hospitals Can Participate in CARES Act Loan Program
  • 4-3-20: Holland & Knight Healthcare Blog on Covid-19 Funding for Healthcare Providers


  • CDC Guidance for Healthcare Providers
  • Covid-19 and Healthcare Facilities Guidance




  • SAMHSA letter to AATOD confirming that OTPs provide essential health services and are legitimate personal protective equipment purchasers
  • SAMHSA Covid-19 Resources and Information
  • Social Distancing, Quarantine, and Isolation Guidance
  • Considerations for Mental Health and SUD Treatment
  • Considerations for Alcohol-Benzodiazephine Withdrawal
  • OTP Guidance
  • OTP Doorstep Delivery Guidance
  • 42 CFR Part 2 Guidance
  • Virtual Recovery Resources
  • Disaster Planning Handbook


  • Covid-19 Emerging Trends and Alerts
  • Covid-19 Potential Implications for Individuals with SUD

HHS Office for Civil Rights

National Academy for State Health Policy

  • State Strategies for OUD Treatment During Covid-19 Pandemic

American Society of Addiction Medicine

ASAM Covid-19 Resources (4-2-20)

Personal Protective Equipment (PPE)


  • CMS Announces Relief for Quality Reporting Programs
  • CMS Guidance for Healthcare Providers
  • CMS Virtual Toolkit
  • CMS Guidance on section 1135 authority that allows waiver of certain Medicare, Medicaid, and Children’s Health Insurance Program (CHIP) requirements


  • CMS Covid-19 and EMTALA Memo
  • CMS Guidance on 1135 Waiver Authority


  • 4-6-20: CMS Video on Telehealth Benefits Questions
  • 4-2-20: DEA and SAMSHA Release Guidance on Buprenorphine and Telemedicine
  • 3-24-20: CMS Telehealth March 24 FAQs
  • CMS 2020 Telehealth Services Booklet
  • Telehealth Coverage Policies Summary from the Center for Connected Health Policy
  • CMS Guidance and FAQs on Telehealth in Medicare
  • CMS Guidance on Telehealth in Medicaid
  • HHS Office of Inspector General (OIG) Policy Statement and Fact Sheet on Telehealth Cost-Sharing
  • HHS Office for Civil Rights Guidance on Waiver of HIPAA Sanctions and Penalties Related to Telehealth
  • Drug Enforcement Administration Guidance on Telemedicine and Medication-Assisted Treatment


  • 4-6-20: OIG Statement on Administrative Enforcement Authorities due to Covid-19 Emergency
  • 4-6-20: Federal Trade Commission Webpage About Covid-19 Consumer Protections
  • Updated 4-2-20: U.S. Labor Department’s FAQs on the Families First Coronavirus Response Act 
  • HHS’ Office of Inspector General released a COVID-19 Fraud Alert with general information
  • Kaiser Family Foundation Medicaid Emergency Authority Tracker
  • National Governors Association Covid-19 Updates
  • HHS Office of Inspector General’s Covid-19 Portal
  • The Joint Commission’s Webinar on Preparing Behavioral Health Organizations for Covid-19
  • HRSA Covid-19 Funding, Resources, and Oversight FAQs
  • HRSA Technical Assistance for Award Recipients

NABH Covid-19 Task Force

NABH’s Covid-19 Task Force works with the NABH team in Washington to identify the most challenging issues facing U.S. behavioral healthcare providers during the Covid-19 pandemic. The task force will also develop recommendations that NABH will share with relevant federal agencies, congressional offices, and the general public.

  • Anne Kelly, Ed.D., B.S.N., Chair, Acadia Healthcare
  • John Boyd, PsyD., F.A.C.H.E., Sutter Health, System Mental Health Services
  • Brian J. Brooker, DHSc, RN-BC NE-BC, M.H.A., H.A.C.P., C.A.R.T., Signature Healthcare Services
  • Pat Connell, R.N., M.B.A., F.A.C.H.E., C.B.H.E., C.H.C., Boys Town Behavioral Health Division
  • Frank Fortunati, Jr., M.D., J.D., Yale New Haven Psychiatric Hospital
  • Michael Genovese, M.D., J.D., Acadia Healthcare, Inc.
  • Frank A. Ghinassi, Ph.D., A.B.P.P., Chair, Rutgers University Behavioral Health Care
  • Michele Gougeon, McLean Hospital
  • Karen Johnson, M.S.W., Universal Health Services, Inc.
  • Chris Roussos, Sequel Youth and Family Services
  • Francis Sauvageau, New Season/Colonial Management Group, LP
  • Mark Schneider, Vizion Health, LLC
  • Dominic Sirianni, L.M.H.C., C.A.P., Delphi Behavioral Health Group
  • Kristen Tefft, M.H.I., R.H.I.A., Springstone, Inc.
  • Harsh K. Trivedi, M.D., M.B.A., Sheppard Pratt Health System
  • Kirsten K. Beronio, J.D., Staff Liaison,  National Association for Behavioral Healthcare